West Pharmaceutical Services, Inc. (FRA:WPS)
Germany · Delayed Price · Currency is EUR 192.40
-3.20 (-1.64%)
At close: Jan 30, 2026
FRA:WPS Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 491.7 | 492.7 | 593.4 | 585.9 | 661.8 | 346.2 |
Depreciation & Amortization | 165.1 | 155.4 | 137.3 | 120.6 | 122.3 | 109.1 |
Loss (Gain) From Sale of Assets | - | - | 11.6 | - | - | - |
Asset Writedown & Restructuring Costs | 12.3 | 7.3 | 9.6 | 21.5 | 5.6 | 7.7 |
Loss (Gain) on Equity Investments | -13.4 | -13.4 | -14.3 | -18.1 | -17.4 | -15.8 |
Stock-Based Compensation | 21.4 | 18.7 | 23.3 | 23.7 | 37.5 | 34 |
Other Operating Activities | -4.9 | -10.2 | 36 | 5.4 | -27.7 | 1.6 |
Change in Accounts Receivable | -58.8 | -58.8 | 4 | -35.6 | -123.5 | -46.6 |
Change in Inventory | 42 | 42 | -13.5 | -49.8 | -86.5 | -73.7 |
Change in Accounts Payable | 2.9 | 2.9 | 4.4 | -2.8 | 16.8 | 36.6 |
Change in Other Net Operating Assets | 35.5 | 16.8 | -15.3 | 73.2 | -4.9 | 73.4 |
Operating Cash Flow | 693.8 | 653.4 | 776.5 | 724 | 584 | 472.5 |
Operating Cash Flow Growth | -1.22% | -15.85% | 7.25% | 23.97% | 23.60% | 28.68% |
Capital Expenditures | -314.7 | -377 | -362 | -284.6 | -253.4 | -174.4 |
Cash Acquisitions | - | - | - | - | -2.2 | - |
Other Investing Activities | 0.1 | -1.7 | -6.7 | -3.6 | 2.5 | -5.1 |
Investing Cash Flow | -314.6 | -378.7 | -368.7 | -288.2 | -253.1 | -179.5 |
Long-Term Debt Issued | - | 164.7 | - | - | - | - |
Total Debt Issued | - | 164.7 | - | - | - | - |
Long-Term Debt Repaid | - | -192.3 | -2.4 | -44.3 | -2.2 | -2.3 |
Total Debt Repaid | -0.9 | -192.3 | -2.4 | -44.3 | -2.2 | -2.3 |
Net Debt Issued (Repaid) | -0.9 | -27.6 | -2.4 | -44.3 | -2.2 | -2.3 |
Issuance of Common Stock | 16.7 | 32.7 | 51 | 28.2 | 37.1 | 34.7 |
Repurchase of Common Stock | -191.2 | -566.6 | -451.2 | -222.2 | -151.9 | -121.4 |
Common Dividends Paid | -60.7 | -59.1 | -57 | -54.1 | -51.1 | -48.1 |
Other Financing Activities | -6.2 | -2 | - | -1.2 | - | - |
Financing Cash Flow | -242.3 | -622.6 | -459.6 | -293.6 | -168.1 | -137.1 |
Foreign Exchange Rate Adjustments | 0.7 | -21.4 | 11.4 | -10.5 | -15.7 | 20.5 |
Net Cash Flow | 137.6 | -369.3 | -40.4 | 131.7 | 147.1 | 176.4 |
Free Cash Flow | 379.1 | 276.4 | 414.5 | 439.4 | 330.6 | 298.1 |
Free Cash Flow Growth | 17.88% | -33.32% | -5.67% | 32.91% | 10.90% | 23.80% |
Free Cash Flow Margin | 12.56% | 9.55% | 14.05% | 15.22% | 11.68% | 13.88% |
Free Cash Flow Per Share | 5.20 | 3.75 | 5.50 | 5.80 | 4.33 | 3.93 |
Cash Interest Paid | 0.5 | 0.5 | 6 | 6.6 | 8 | 8.1 |
Cash Income Tax Paid | 71.4 | 71.4 | 90.8 | 109.7 | 171.8 | 48.4 |
Levered Free Cash Flow | 251.19 | 206.73 | 196.35 | 246.54 | 210.05 | 250.4 |
Unlevered Free Cash Flow | 251.19 | 208.6 | 201.98 | 251.48 | 215.18 | 255.53 |
Change in Working Capital | 21.6 | 2.9 | -20.4 | -15 | -198.1 | -10.3 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.